The Board found that the Veteran's herpes progenitalis with balanitis did not warrant a compensable rating prior to January 21, 2015 and denied entitlement to a 10 percent rating beginning on January 21, 2015.
The deciding factor: The medical evidence showed that the area affected by the service-connected disability was less than 5% of his total body or exposed areas, and no systemic therapy such as corticosteroids or other immunosuppressive drugs were required during the past 12 months.
- Claimed conditions
- Herpes Progenitalis, Balanitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- May 13, 2016
- Citation
- 1619522
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1619522.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's herpes progenitalis is rated at 10 percent prior to December 30, 2021, and remains at 10 percent from December 30, 2021, to December 30, 2022. After that date, a higher rating is not warranted.
- Partly granted
The Board granted service connection for balanitis as secondary to diabetes mellitus, type 2 and denied increased ratings for diabetes mellitus, type 2, bilateral lower extremity diabetic neuropathy, coronary artery disease, and an earlier effective date for special monthly compensation.
- Remanded (sent back)
The Veteran's herpes progenitalis is rated as noncompensably disabling. The Board has ordered a remand to determine the nature and duration of treatment for his condition, including whether it constitutes systemic therapy.
- Denied
The Veteran's herpes progenitalis with balanitis was rated at 10 percent prior to January 21, 2014. The Board found that the evidence did not demonstrate systemic therapy or affected areas meeting the criteria for a higher rating.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.